Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001651308-24-000014
Filing Date
2024-02-26
Accepted
2024-02-26 06:16:27
Documents
186
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bgne-20231231.htm   iXBRL 10-K 3477080
2 EX-4.6 exhibit46-descriptionofsec.htm EX-4.6 177820
3 EX-10.16 exhibit1016-consultingagre.htm EX-10.16 98360
4 EX-10.21 exhibit1021bmssettlementag.htm EX-10.21 35206
5 EX-19.1 exhibit191-insidertradingp.htm EX-19.1 44511
6 EX-19.2 exhibit192-specialtradingp.htm EX-19.2 111230
7 EX-21 exhibit21-2023q4beigeneltd.htm EX-21 66099
8 EX-23.1 exhibit231-2023q4.htm EX-23.1 7788
9 EX-23.2 exhibit232-2023q4.htm EX-23.2 7872
10 EX-31.1 exhibit311-2023q4.htm EX-31.1 9728
11 EX-31.2 exhibit312-2023q4.htm EX-31.2 9720
12 EX-32.1 exhibit321-2023q4.htm EX-32.1 6248
13 EX-97 exhibit97-compensationreco.htm EX-97 36095
14 EX-99.1 exhibit991-disclosureforei.htm EX-99.1 3154
20 bgne-20231231_g1.jpg GRAPHIC 16225
21 bgne-20231231_g10.jpg GRAPHIC 212464
22 bgne-20231231_g11.jpg GRAPHIC 25568
23 bgne-20231231_g12.jpg GRAPHIC 14465
24 bgne-20231231_g13.jpg GRAPHIC 14179
25 bgne-20231231_g14.jpg GRAPHIC 10551
26 bgne-20231231_g15.jpg GRAPHIC 7996
27 bgne-20231231_g16.jpg GRAPHIC 17228
28 bgne-20231231_g17.jpg GRAPHIC 4825
29 bgne-20231231_g18.jpg GRAPHIC 99159
30 bgne-20231231_g19.jpg GRAPHIC 754873
31 bgne-20231231_g2.jpg GRAPHIC 54344
32 bgne-20231231_g20.jpg GRAPHIC 42991
33 bgne-20231231_g21.jpg GRAPHIC 41349
34 bgne-20231231_g22.jpg GRAPHIC 91845
35 bgne-20231231_g23.jpg GRAPHIC 9221
36 bgne-20231231_g24.jpg GRAPHIC 26120
37 bgne-20231231_g25.jpg GRAPHIC 5314
38 bgne-20231231_g26.jpg GRAPHIC 6570
39 bgne-20231231_g27.jpg GRAPHIC 7770
40 bgne-20231231_g28.jpg GRAPHIC 274319
41 bgne-20231231_g3.jpg GRAPHIC 26217
42 bgne-20231231_g4.jpg GRAPHIC 6104
43 bgne-20231231_g5.jpg GRAPHIC 22676
44 bgne-20231231_g6.jpg GRAPHIC 14582
45 bgne-20231231_g7.jpg GRAPHIC 45410
46 bgne-20231231_g8.jpg GRAPHIC 20230
47 bgne-20231231_g9.jpg GRAPHIC 13210
  Complete submission text file 0001651308-24-000014.txt   21265382

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20231231.xsd EX-101.SCH 113962
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20231231_cal.xml EX-101.CAL 135403
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20231231_def.xml EX-101.DEF 615093
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20231231_lab.xml EX-101.LAB 1237612
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20231231_pre.xml EX-101.PRE 941090
188 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20231231_htm.xml XML 2424590
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37686 | Film No.: 24673471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)